Ausgabe 9/2017
Inhalt (10 Artikel)
Celiac disease: from etiological factors to evolving diagnostic approaches
Anantdeep Kaur, Olga Shimoni, Michael Wallach
Clinical practice guideline for post-ERCP pancreatitis
Tetsuya Mine, Toshio Morizane, Yoshiaki Kawaguchi, Ryukichi Akashi, Keiji Hanada, Tetsuhide Ito, Atsushi Kanno, Mitsuhiro Kida, Hiroyuki Miyagawa, Taketo Yamaguchi, Toshihiko Mayumi, Yoshifumi Takeyama, Tooru Shimosegawa
Diagnostic accuracy of demarcation of undifferentiated-type early gastric cancer after Helicobacter pylori eradication
Yusuke Horiuchi, Junko Fujisaki, Noriko Yamamoto, Masami Omae, Akiyoshi Ishiyama, Toshiyuki Yoshio, Toshiaki Hirasawa, Yorimasa Yamamoto, Tomohiro Tsuchida, Hiroshi Takahashi
Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis
Yasuo Suzuki, Satoshi Motoya, Hiroyuki Hanai, Toshifumi Hibi, Shiro Nakamura, Andreas Lazar, Anne Martin Robinson, Martha Skup, Nael Mohamed Mostafa, Bidan Huang, Roopal Thakkar, Mamoru Watanabe
Natural history of chronic hepatitis B virus infection in children in Japan: a comparison of mother-to-child transmission with horizontal transmission
Tomoko Takano, Hitoshi Tajiri, Satoyo Hosono, Ayano Inui, Jun Murakami, Kosuke Ushijima, Yoko Miyoshi, Yuri Etani, Daiki Abukawa, Mitsuyoshi Suzuki, Stephen Brooks
Effects of vaccine-acquired polyclonal anti-HBs antibodies on the prevention of HBV infection of non-vaccine genotypes
Masaki Kato, Susumu Hamada-Tsutsumi, Chiaki Okuse, Aiko Sakai, Nobuyuki Matsumoto, Masaaki Sato, Toshiyuki Sato, Mitsumi Arito, Kazuki Omoteyama, Naoya Suematsu, Kazuki Okamoto, Takanobu Kato, Fumio Itoh, Ryo Sumazaki, Yasuhito Tanaka, Hiroshi Yotsuyanagi, Tomohiro Kato, Manae Suzuki Kurokawa
Deep sequencing analysis of quasispecies in the HBV pre-S region and its association with hepatocellular carcinoma
An-Ye Zhang, Ching-Lung Lai, Fung-Yu Huang, Wai-Kay Seto, James Fung, Danny Ka-Ho Wong, Man-Fung Yuen
Comment to: “Management and outcome of gastrointestinal bleeding in patients taking oral anticoagulants or antiplatelet drugs”
Marko Lucijanic, Sead Ziga, Ivica Grgurevic
Erratum to: Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis
Yasuo Suzuki, Satoshi Motoya, Hiroyuki Hanai, Toshifumi Hibi, Shiro Nakamura, Andreas Lazar, Anne Martin Robinson, Martha Skup, Nael Mohamed Mostafa, Bidan Huang, Roopal Thakkar, Mamoru Watanabe